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Intensive Care Unit addmission in one state (thus unable to include in multivari-
able analysis) and women’s weight, a known risk factor among women with
PCOS. Additionally we had no data to assess environmental exposure.
Wider implications of the ﬁndings: The hormonal proﬁle of women/mothers
withPCOSwhounderwentARTmayexplain the impact on their health, pregnancy
andoffspring, compared towomenwithTO.Preventionstrategies targeted towards
improving themetabolic and endocrine consequencesofPCOS, suchasoptimizing
thehealth ofwomenwith the syndromeprior to conception throughchanges in life-
style, diet and appropriatevitaminsupplementation, shouldbeconsidered.Dongso
could reduce the health risk and economic burden of PCOS.
Study funding/competing interest(s): No funding and competing interest(s) to
report
Trial registration number: Not applicable
O-020 The inﬂuenceof sex steroids on theneuronal correlates ofworking
memory in women with Polycystic Ovarian Syndrome
R. Soleman1,, B.P.C. Kreukels2, D.J. Veltman3, P.T. Cohen-Kettenis2,
P.G.A. Hompes4, M.L. Drent5, and C.B. Lambalk1
1VU University Medical Center, Obstetrics and Gynaecology, Amsterdam, The
Netherlands, 2VU University Medical Center, Medical Psychology, Amsterdam,
The Netherlands, 3VU University Medical Center, Psychiatry, Amsterdam, The
Netherlands, 4VU University Medical Center, Obstretrics and Gynaecology,
Amsterdam, The Netherlands, 5VU University Medical Center, Endocrinology,
Amsterdam, The Netherlands
Studyquestion:Theaimof the studywas to investigate speciﬁc effects of an over-
production of androgens on brain activity during working memory processes in
women with a Polycystic Ovarian Syndrome (PCOS)
Summary answer: Our main conclusion is that women with PCOS need add-
itional resources during a working-memory task, suggesting less efﬁcient execu-
tive functioning with regard to working-memory compared to women without
PCOS
What is known already:Working-memory is a speciﬁc cognitive component of
temporal storage and manipulation of information and is needed for multiple pro-
cesses of cognition, such as language, perceptual speed, but also verbal and visual
memory and planning. Possible deﬁcits may affect daily functioning and behav-
iour. This is the ﬁrst MRI study with a focus to working-memory in women
with PCOS and hyper androgenism.
Study design, size, duration: In this study we used a cross-sectional design
between women with PCOS with hyper androgenism compared to women
without PCOS (controls). In total, we investigated 34 participants (fourteen
women with PCOS and twenty controls with the use of functional MRI, a neuro-
psychological assessment and blood samples were withdrawn.
Participants/materials, setting, methods: Fourteen women with PCOS com-
bined with hyper androgenism and 20 controls underwent functional MRI scan-
ning while performing a working memory task (N-Back). During this task
participants monitored a series of letters and were asked to indicate whether this
letter was also presented n (n ¼ 1, 2 or 3) steps previously.
Main results and the role of chance: Analysis of the blood samples showed
higher levels of androgens in the PCOSgroup (p ¼ 0.009). The task performance
did not differ between the two groups for mean reaction time nor accuracy of the
answers.However, brain activation patterns did differ signiﬁcantly between the
twogroups.ThegroupwithPCOSshowedmoreactivationwithin the superiorpar-
ietal lobe right and the inferior parietal lobe left during all given N-Back stimuli.
This ﬁndingmaysuggest thatwomenwithPCOSneed additional resources during
aworking-memory task, suggesting less efﬁcient executive functioning compared
to women without PCOS.
Limitations, reason for caution: Because we only wanted to include homoge-
neous groups of participants to reduce the risk of possible confounds, recruitment
of which proved to be burdensome.
Wider implications of the ﬁndings: This is the ﬁrst study investigating the spe-
ciﬁc effects ofPCOS tobrain activity. These results suggest less efﬁcient executive
functioning inwomenwithPCOS.Although the changesare rather subtle it should
be investigatedmore in depth to investigate if the efﬁciencyof brain activity is less
inmore cognitive domains. Inefﬁciency in brain activity ofworkingmemory com-
binedwith other cognitive deﬁcitsmayaffect daily life functioning inwomenwith
PCOS more.
Study funding/competing interest(s):This workwas supported by and Founda-
tion for gynaecological research and education, VUmc, Amsterdam, the Nether-
lands and Neuroscience Campus, Amsterdam, the Netherlands
Trial registration number: This trial is registered to the Dutch trial register
(www.http://www.trialregister.nl/) (NTR: 2493)
SELECTED ORAL COMMUNICATION SESSION
Session 05: Sperm factors inﬂuencing ART
outcome
Monday 8 July 2013 10:00 - 11:30
O-021 Does the extent of sperm DNA fragmentation affect IVF or ICSI
outcome: a systematic review and meta analysis
A. Osman, H. Alsomait, S. Seshadri, Y. Khalaf, and T. El Toukhy
Guys Hospital, Assisted conception unit, London, United Kingdom
Study question:Does the literature suggest that high sperm DNA damage affect
IVF and ICSI outcome?
Summary answer: High sperm DNA damage detected with SCSA, TUNEL or
COMET assays has been shown to be associated with lower clinical pregnancy
rates in IVF cycles.
What isknownalready:SpermDNAdamage is found in infertile aswell as fertile
men. The relationship between spermDNAdamage and fertilization rate, embryo
quality, pregnancy andmiscarriage rates has been evaluated in the literature. It has
beendemonstrated thatDNAdamaged spermhave the capacity to fertilize oocytes
but could be associated with an increase in the miscarriage rate following ART
(assisted reproductive technique).
Studydesign, size, duration:Asystematic reviewandmeta-analysis of studieson
the effect of high spermDNAfragmentation rate on IVF/ICSIoutcomewas under-
taken.Medline, Embase andCochrane library databaseswere searched from data-
base inception to January 2013. The search was limited to studies published in
English language.
Participants/materials, setting, methods: Study selection and data extraction
were conducted independently by two reviewers. We used ’sperm DNA damage’,
’DNAfragmentation’, ’IVF’,’ICSI’, ’outcome’, ’pregnancy’ to generate the relevant
citation. Studies with clinical pregnancy outcome (gestational sac or fetal heart on
USS) were included. Revman 5 statistical software was used for analysis.
Main results and the role of chance: The search identiﬁed 25 studies involving
3360 couples.
ForSCSAassay:Meta-analyses of 14 studies (n ¼ 1621) showed a signiﬁcant-
lyhigherclinical pregnancy rate (CPR) in thegroupwhohadaDNAfragmentation
index (DFI) score of ,30% (Relative risk (RR) 1.17, 95% CI 1.05-1.30; P ¼
0.004) compared to the group who had a DFI .30%.
For TUNEL assay: Meta-analyses of 8 studies (n ¼ 1233) showed a signiﬁ-
cantly higher CPR in the group who had a low DNA fragmentation compared to
the group who had a high DNA fragmentation (RR 0.69, 95%CI 0.52-0.90, P¼
0.006).
ForComet assay: Meta-analyses of 3 studies (n¼ 506) showed a signiﬁcantly
higherCPR in thegroupwhohada lowDNAfragmentationcompared to thegroup
with high DNA fragmentation (RR 1.16, 95%CI, 1.03-1.30, P ¼ 0.01).
Limitations, reason for caution: There has been several assays described in the
literature to deﬁne low and high DNA fragmentation. The diagnostic accuracy of
these assays has been widely debated. There is inconsistency in deﬁning the
threshold for high DNA fragmentation test. The studies included were heteroge-
neous and not adequately powered.
Wider implications of the ﬁndings: Increased sperm DNA fragmentation may
have a detrimental effect on IVF outcome. Adequately powered studies with
strict inclusion criteria to further evaluate the effect of DNA fragmentation
testing in IVF and the role of antioxidants as well as IMSI (intracytoplasmic mor-
phologically selected sperm injected) as treatment options are needed.
Study funding/competing interest(s): none
Trial registration number: none
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O-022 Novel detection of intratubular germ cell neoplasia in non-
obstructive azoospermiausingOCT3/4andPLAP inAgarCytos of testicular
sperm extraction specimens
M.Hesse1,, L.Ramos1,A.F.C.Hulsbergen2,K.W.M.d’Hauwers3,D.D.M.Braat1,
and C.A. Hulsbergen-van de Kaa2
1Radboud University Nijmegen Medical Centre, Obstetrics & Gynaecology,
Nijmegen, The Netherlands, 2Radboud University Nijmegen Medical Centre,
Pathology, Nijmegen, The Netherlands, 3Radboud University NijmegenMedical
Centre, Urology, Nijmegen, The Netherlands
Study question: Can we diagnose intratubular germ cell neoplasia (IGCN) using
the immunohistochemical markers placental-like alkaline phosphatase (PLAP)
andOCT3/4onAgarCytos,madeof the remnants of the testicular spermextraction
(TESE) specimen, andwhat is the incidenceof such (pre)malignancies inmenwith
non-obstructive azoospermia (NOA) undergoing TESE for fertility treatment?
Summary answer: For the ﬁrst time, IGCN can be successfully detected by
immunohistochemical evaluation of AgarCytos, made of the remnants of TESE
biopsies. The observed incidence of a germ cell (pre)malignancy in this speciﬁc
population was 4.4%.
What is knownalready: Infertilemen are at higher risk for testicular cancer com-
pared to the general population. IGCN can be detected by immunohistochemistry
in standard testicular biopsies and, albeit less accurate, in semen using PLAP and
OCT3/4.
Study design, size, duration:Between January 2011 and April 2012 a prospect-
ive cohort studywas conducted at aDutch tertiary care academic training hospital.
All males with NOA (n ¼ 182) undergoing a urological work-up followed by a
diagnostic TESE (n ¼ 251) for fertility treatment were included.
Participants/materials, setting, methods: After cryopreservation of sperm, if
present, an AgarCytowasmade of the remnants of these TESE biopsies. Sections
were stained with haematoxylin-eosin for pathological examination as well as
PLAP and OCT3/4 for immunohistochemistry to detect IGCN.
Main results and the role of chance: Eight men (4.4%) were diagnosed with a
germ cell (pre)malignancy: six with seminoma, of which two without and four
withconcomitant IGCN,andtwowithIGCNonly.Microscopicevaluation including
immunohistochemical analysis of theAgarCytos diagnosed three (1.6%)more cases
of a germ cell (pre)malignancy compared to scrotal ultrasound alone (one case of bi-
lateral seminomawith concomitant IGCN and two cases of IGCN alone). No false-
positive cytology results were found upon conventional histological evaluation.
Limitations, reason for caution: The main limitation of this study is lack of a
simultaneously taken standard testicular biopsy, for comparison with our novel
diagnostic method. Nevertheless, in all but one of our cases orchidectomy fol-
lowed and the diagnosis was conﬁrmed by histology, in the remaining case
repeat TESE showed similar results.
Wider implications of the ﬁndings: Men undergoing TESE because of NOA
should be offered simultaneous screening for IGCN because of the increased in-
cidence of germ cell (pre)malignancies in this speciﬁc population. The principal
advantage of our new method is that all available testicular tissue can be used for
both sperm recovery and pathological evaluation, increasing the yield of sperm-
atozoa as well as the chance to ﬁnd (pre)malignant cells.
Study funding/competing interest(s): This study was (partially) funded by
Merck Serono (Schiphol-Rijk, theNetherlands), but there are no conﬂicting inter-
ests to disclose.
Trial registration number: N/A
O-023 Evaluating the etiopathogenic factors of DNA damage in sperm
with large nuclear vacuoles
F. Bourrou1,, J.B.A.Oliveira2, C.G. Petersen2, L.D.Vagnini3, A.M.Nascimento3,
A.L. Mauri1, F.C. Massaro1, A. Nicoletti1, A. Pontes4, M. Cavagna5,
R.L.R. Barufﬁ1, and J.G. Franco, Jr.2
1Centre for HumanReproduction Prof. Franco Jr / Paulista Centre for Diagnosis
Research and Training, Research, Ribeirao Preto, Brazil, 2Centre for Human
Reproduction Prof. Franco Jr / Paulista Centre for Diagnosis Research and
Training / Department of Gynecology and Obstetrics Botucatu Medical School
Sa˜o Paulo State University - UNESP, Research, Ribeirao Preto, Brazil, 3Paulista
Centre for Diagnosis Research and Training, Research, Ribeirao Preto, Brazil,
4Department of Gynecology and Obstetrics Botucatu Medical School Sa˜o Paulo
State University - UNESP, Research, Botucatu, Brazil, 5Centre for Human
Reproduction Prof. Franco Jr / Paulista Center for Diagnosis Research and
Training /Women’sHealthReferenceCenterPerolaByingtonHospital,Research,
Ribeirao Preto, Brazil
Study question: Is there a relationship between the etiopathogenic factors of
DNA damage and the presence of large nuclear vacuoles (vacuoles occupy
.50% of the nuclear area) in sperm?
Summary answer:Our results support the idea that the presence of large nuclear
vacuoles in sperm could reﬂectmolecular anomalies, such as abnormal chromatin
packaging (underprotamination), mitochondrial damage and apoptosis.
What is known already: There is strong clinical evidence supporting an associ-
ation between increasedDNAdamage in spermand abnormalities in several char-
acteristics of semen. Several studies have linked the presence of large nuclear
vacuoles (LNV) and increased DNA damage in sperm based on high magniﬁca-
tion analyses. Different mechanisms may explain the presence of damaged DNA
in human spermatozoa, including abnormal chromatin packaging (underprotami-
nation), mitochondrial damage and apoptosis.
Studydesign, size, duration:Across-sectional study of semen samples obtained
from 608menwho underwent infertility evaluations was conducted fromAugust
2010 to August 2012. Percentages were treated as continuous variables. Correl-
ation analyses were performed using Spearman’s rank test.
Participants/materials, setting, methods: At least 200 spermatozoa per evalu-
ation were examined from each semen sample. The percentages for the following
groups were determined:
-Normal and LNV spermatozoa bymotile sperm organelle morphology exam-
ination(MSOME/15,000x magniﬁcation);
-Spermatozoa with abnormal chromatin packaging (chromomycin A3);
-Spermatozoa with mitochondrial damage (MitoTracker Green);
-Spermatozoa in apoptosis (positive for annexin-V).
Main results and the role of chance:Regression analysis revealed that abnormal
chromatinpackaging,mitochondrial damage and apoptosiswere positively corre-
lated with the percentage of LNV spermatozoa. Conversely, regression analysis
revealed that abnormal chromatin packaging and mitochondrial damage were
negatively correlatedwith the percentage of normal sperm.A signiﬁcant relation-
ship with apoptosis was not observed (Table 1).
Limitations, reason for caution: This descriptive study was based on in vitro
evaluations.Cross-sectional analyses do not allow inferences regardingdirection-
ality between observed associations. Therefore, determining the cause and effect
between variables is not possible.
Wider implicationsof theﬁndings:Basedon the clinical and laboratoryﬁndings
regarding the repercussions of possible DNA damage in offspring, these data in-
dicate that the use of spermatozoawith LNVshould be avoided to obtain embryos
with higher implantation and development potential.
Study funding/competing interest(s): The authors declare that they have no
competing interests.
Trial registration number: Not applicable. The local ethics committee
authorised this study.
O-024 Punalpinw increases the numbers of motile sperm in men with
reduced semen quality: a prospective, randomized, controlled, double-
blinded trial
M.D.Kaspersen1,,H.B. Jakobsen2, I. Giversen2, L.P.Christensen3, and J. Fedder4
1Laboratory of Reproductive Biology, Scientiﬁc Unit Regional Hospital of
Horsens, Horsens, Denmark, 2Nerthus ApS, Nerthus Aps, Lejre, Denmark,
3Department of Chemical Engineering Biotechnology and Environmental
Technology, Faculty of Engineering University of Southern Denmark, Odense,
Denmark, 4Fertility Clinic, Department D Odense University Hospital, Odense,
Denmark
Study question: Does oral consumption of tablets containing standardized
amounts of greater galangal (Alpinia galanga) and extract of pomegranate
(Punica granatum) increase the total number of motile spermatozoa?
Summaryanswer:After threemonths of daily intake of Punalpinw consisting of
tablets containing standardizedamountsof rhizomeofgreatergalangal andextract
of pomegranate fruit skin the total numberofmotile spermatozoawas signiﬁcantly
increased compared to placebo.
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What is known already: Juice from pomegranate fruit has been shown to stimu-
late spermatogenesis and to increase sperm motility in rats after seven weeks of
gavage (Tu¨rk et al. 2008), and increased sperm counts and motility have been
shown in mice, which were given galangal extract for 90 days (Qureshi et al.
1992). Within traditional medicine, pomegranate fruit has long been used to in-
crease fertility, however studies on the effect on spermatogenesis in humans
have never been published.
Study design, size, duration: The study was designed as a prospective, rando-
mized, controlled, double-blinded trial. Seventy men with base-line total motile
sperm less than 40 million were randomized to take tablets corresponding to ap-
proximately 3.5 g fresh galangal rhizome and 1500 ml pomegranate fruit juice
or placebo daily for three months.
Participants/materials, setting, methods: Participants were recruited from ad-
vertisement in Nordic Cryobank and local newspapers. Enrollment was based
on mean total number of motile spermatozoa of two ejaculates (with 4-10 days
of abstinence). The participants delivered an ejaculate after 4-8 days of
tablet-intake and two ejaculates just before they stopped taking the tablets.
Main results and the role of chance: From baseline to after three months of
Punalpinw intake corresponding to a daily dose of 11 mg ellagic acid, 100 mg
punicalagin A, 265 mg punicalagin B (from pomegranate) and 16 mg
1’-acetoxychavicol acetate (from galangal) the average total number of motile
sperm increased with 62% (from 23.4 millions to 37.8 millions), while for the
placebogroup thenumberofmotile sperm increasedwith20%(from19.9millions
to23.9millions).This difference in increase between the studyandplacebogroups
was statistically signiﬁcant (p ¼ 0.026). There was no increase in number of
motile sperm after one week of tablet consumption for either of the groups, indi-
cating that the pomegranate and galangal preparations exert their positive effect
during spermatogenesis rather than on epididymal sperm.
Limitations, reason for caution: It cannot be expected that every participant take
100% of the tablets for the three-months period. The counting of the remaining
tablets of all bottles showed that more than 85% of the participants had taken
more that 80% of the tablets.
Wider implications of theﬁndings:Our ﬁndingsmay help subfertilemen to gain
an improved amount of motile ejaculated sperm by taking tablets containing pre-
parations of pomegranate fruit skin and rhizome of greater galangal. Consequent-
ly, these men may become able to impregnate their partner by natural conception
rather than exclusively by ART, or implied fertility treatments may be less inva-
sive. Ultimately, the load on fertility clinics may be reduced.
Study funding/competing interest(s): The study was funded by Center for
Science and Research of Alternative Treatment (VIFAB). Two of the authors (2)
are working on commercializing the product.
Trial registration number: Approved by the Danish Data Protection Agency
(J.nr. 2012-41-5441), the local Scientiﬁc Ethics Committee (M-20100247) and
ClinicalTrials.gov (ID NCT01357044).
O-025 Is morphologically selected sperm injection with ejaculated
spermatozoa useful for non-selected patients
N. Inoue, A. Yoshida, S. Tanigiwa, K. Seida, H. Suzuki, and M. Tanaka
Kiba Park Clinic, Tokyo, Japan
Study question: Is there any difference of outcome between morphologically
selected sperm injection (IMSI)with ejaculated spermatozoa and ICSIwith ejacu-
lated spermatozoa?
Summary answer: The top-quality embryo rate on day 3 and the blastocyst for-
mation rate on day 5 by IMSI were signiﬁcantly higher than those by ICSI.
However, there is no difference of the implantation rate and the delivery rate
between the two groups.
What is known already: Morphological selection of fertilizing spermatozoa
under a high magniﬁcation has been introduced to provide a better clinical
outcome than the conventional ICSI. However, it is still a controversial issue
whether human sperm head vacuoles affect ICSI outcome or not. Most of the
earlier studies showed no effectiveness of IMSI.
Studydesign, size, duration:This is a retrospective analysis of outcome in 9,005
oocytes with IMSI and 8,070 oocytes with ICSI conducted for women under the
age of 40 from 2007 to 2012.
Participants/materials, setting,methods:Almost one half theMII oocyteswere
inseminated by IMSI with ejaculated spermatozoa and the other by conventional
ICSIwith ejaculated spermatozoa. During the IMSI,motile spermwith best avail-
ablemorphologywere selected. Embryo transferswere performedwith only IMSI
or ICSI derived embryos.
Main results and the role of chance: The normal fertilization rate by IMSI
(68.4% 6156/9005) was comparable with ICSI (67.9% 5478/8070). The top-
quality embryo rate on day 3 by IMSI (53.6% 3301/6156) was signiﬁcantly
higher than that by ICSI (51.2% 2804/5478). The blastocyst formation rate on
day 5 by IMSI (62.9% 3448/5486) was also signiﬁcantly higher than that by
ICSI (60.7% 2978/4905). However, the implantation rate by IMSI (38.2% 224/
586)was comparablewith that by ICSI (38.7%177/457). Therewas no signiﬁcant
difference in the delivery rate between the two groups (32.3% 158/489 vs 35.4%
138/390). Mean birth weight by IMSI (2946.9+486.6g) was comparable with
that by ICSI (3009.0+403.3g ). Therewas no signiﬁcant difference in congenital
abnormality rate between the two groups (0.0% vs 0.7%).
Limitations, reason for caution: Long term follow-up of children by IMSI and
ICSI, including motor and psychological development, is recommended in
order to evaluate difference between IMSI and ICSI.
Wider implications of the ﬁndings: Embryo development by IMSI with ejacu-
lated spermatozoa was signiﬁcantly higher than that by ICSI. However, there is
no difference of clinical outcome such as the delivery rate.
Study funding/competing interest(s):This studywasnot fundedand there areno
conﬂicts of interest.
Trial registration number: n/a
O-026 Motile sperm organellar morphology examination (MSOME):
interest to predict clinical outcome of ICSI
I. Heilikman1,, K. Pocate2, R. Porcher3, V. Barraud-Lange2, N. Sermondade1,
C. Dupont1, J.P. Wolf2, and C. Sifer1
1Jean Verdier University Hospital, IVF Laboratory Unit, Bondy, France,
2Cochin-Port Royal University Hospital, IVF Laboratory Unit, Paris, France,
3Saint Louis University Hospital, Bio Statistical Analysis Unit, Paris, France
Study question: The aim of this study is to evaluate if a real-time ultra-
morphology test of motile spermatozoa so-called MSOME and/or standard
sperm morphology assessment could predict IntraCytoplasmic Sperm Injection
(ICSI) outcome in terms of fertilization, embryo quality and clinical pregnancy
rates.
Summary answer: MSOME and standard sperm morphology cannot predict
clinical and biological ICSI outcomes.
What is known already: Some laboratories routinely use MSOME results to in-
dicate ICSI or IMSI (IntraCytoplasmic Morphologically selected Sperm Injec-
tion). Many classiﬁcations of MSOME essentially based on sperm head
examination under high magniﬁcation tries to determine a threshold of sperm
head normalcy rate. An obtained rate under the threshold would recommend the
use of IMSI. However, most of these thresholds are arbitrarily determined and
not evaluated.
Study design, size, duration: This is a prospective observational bicentric study
setting in two public assisted reproductive technologies (ART) units in France
between January and July 2012. A total of 111 ICSI cycles for exclusive male in-
fertility factors were included.
Participants/materials, setting, methods:A Spearman correlation test was per-
formed to validate MSOME reproducibility between ART units. Normal morph-
ology rate and MSOME done on selected spermatozoa were respectively
determined according to David’s and Vanderzwalmen’s classiﬁcations the day
of ICSI. ROC curves analysis was performed to determine thresholds associated
with the occurrence of a pregnancy.
Main results and the role of chance: We observed an excellent correlation
between the two operators (r ¼ 0.98) validating MSOME data of the study. Per-
centages of normal morphology grade spermatozoa using standard classiﬁcation
and ﬁrst-best morphology grade spermatozoa determined by MSOME were not
signiﬁcantly associated with (i) clinical pregnancy (p ¼ 0.58; 0.90 / Area under
curve (AUC) ¼0.532; 0.507), (ii) fertilization (p ¼ 0.88; 0.90), (iii) top quality
embryo (p ¼ 0.27; 0.98) and (iv) good quality embryo rates (p ¼ 0.73; 0.98), re-
spectively.
Limitations, reason for caution: This study is limited by its statistical power
which is not very highdue to the sample size (111 ICSI cycles, 41 clinical pregnan-
cies).
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Wider implications of the ﬁndings: There is a long time controversy about the
meaning of sperm morphology in ART practices and now with the ultra-
morphology assessed by MSOME. This study tries to give an answer in this
decade-old controversy. Because there is no threshold of sperm head normalcy
rate associated with the occurrence of a pregnancy, standard morphology evalu-
ation and/or MSOME should not be used to predict ICSI outcome.
Study funding/competing interest(s): authors declare no funding or competing
interests.
Trial registration number: No Trial registration number.
SELECTED ORAL COMMUNICATION SESSION
Session 06: Endometriosis
Monday 8 July 2013 10:00 - 11:30
O-027 Endometriosis symptom variation by mutually adjusted demo-
graphic characteristics in a cohort of 1000 women
L.F. Carvalho1,, S.A. Missmer2, K.F. Correia2, L.F.C. Fernandes3, and
M.S. Abra˜o3
1University of Sa˜o Paulo, 1Department of Obstetrics and Gynecology Sa˜o Paulo
University Sa˜o Paulo Brazil 2Department of Obstetrics Gynecology and
Reproductive Biology Brigham and Women’s Hospital and Harvard Medical
School Boston MA, Sa˜o Paulo, Brazil, 2Brigham and Women’s Hospital and
Harvard Medical School, 2Department of Obstetrics Gynecology and
Reproductive Biology Brigham and Women’s,, 3University of Sa˜o Paulo,
Department of Obstetrics and Gynecology Sa˜o Paulo University Sa˜o Paulo
Brazil, Sa˜o Paulo, Brazil
Studyquestion:Aredemographic characteristics associatedwith thepresentation
of pain symptoms (including severe dysmenorrea, severe acyclicpelvic pain, in-
testinal symptoms, cyclic urinary symptoms, deep dyspareunia) inpatients with
endometriosis?
Summary answer: Age, race, education, and age at menarche weresigniﬁcant
predictors, independent of each other, of severe dysmenorrhea. Severeacyclic
pelvic pain was signiﬁcantly associated with age, education, maritalstatus, and
parity. Intestinal symptomswere signiﬁcantly associated with race and age at me-
narche.
What is known already: Severe dysmenorrhea is the symptommost commonly
relatedto the reduced quality of life in patients with endometriosis. Although the-
literature has focused on quantifying pain symptoms associated withendometrio-
sis, little is known about the distribution and variation of thesesymptoms by the
patient’s demographic characteristics.
Study design, size, duration: This prospective cohort study from 1998-2010 of
1002patients (median age ¼ 33; range ¼ 29-38)with laparoscopic and histologi-
calconﬁrmation of endometriosis who were unsuccessful treat by medication.
Participants/materials, setting, methods: Relative risks(RR) and 95%-
conﬁdence intervals(CI) frommultivariable Poisson regression models
adjusted for number of diseaselocations(1,2,3,4,5+), age at surgical
diagnosis(14-24;25-29;30-34;35-39;40+), race(white;black;Asian),educatio-
n(elementary;high school;university),marital status(single;married/partnered;di-
vorced/widowed),age at menarche(≤11;12-13;14+), and parity(0;1;2+). This
mutual adjustmentyields associations independent of the other characteristics
investigated.
Main results and the role of chance: Patients aged 14-24 (RR ¼ 1.27,CI ¼
1.06-1.51) and25-29 (RR ¼ 1.18;CI ¼ 1.04-1.35) were more likely to report
severe dysmenorrheacompared to patients 30-34 at diagnosis. Black race com-
pared to white (RR ¼ 1.20,CI ¼ 1.06-1.36), elementaryeducation compared to
college (RR ¼ 1.18,CI ¼ 1.02-1.36), and ≤11 years old at menarchecompared
to 12-13 (RR ¼ 1.15,CI ¼ 1.04-1.28) were also signiﬁcantly associatedwith
greater risk of severe dysmenorrhea. Increased risk of severe acyclic pelvic pain
was found among youngerpatients (RR ¼ 1.57,CI ¼ 1.05-2.35 for those aged
14-24 versus 30-34) and parouspatients (RR ¼ 1.47,CI ¼ 1.15-1.87 versus nul-
liparous). Black race as compared to white(RR ¼ 1.40,CI ¼ 1.07-1.84) and
younger age at menarche (RR ¼ 1.26,CI ¼ 1.03-1.55 for ≤ 11 versus 12-13)
were associatedwith increased riskof intestinalsymptoms.No signiﬁcant associa-
tionswere found between demographic characteristics and cyclic urinary symp-
toms ordeep dyspareunia.
Limitations, reason for caution:Due to missing data, we were only able tocon-
sider body mass index, smoking, physical activity, and family history ofendome-
triosis as predictors of pain on a subset of patients, reducing power andpotentially
generalizability for these additional demographic characteristics.
Wider implications of the ﬁndings: Not only do painsymptoms vary among
women with endometriosis, these symptoms may be more commonwith speciﬁc
demographic characteristics such as age at diagnosis, education,race, parity, and
age at menarche. Thisvariation may lend insight into disease etiology or patterns
of diagnostic delay/ bias.
Study funding/competing interest(s): There was no fundingsupport for this
project.
Trial registration number: This was no a registered trial
O-028 Interleukin-8 in follicular ﬂuid n˜ a promising prognostic marker
for IVF success in women with endometriosis
R. Chattopadhyay1,, A.K. Singh2, S. Roychoudhury2, S. Ghosh1, G. Bose1,
K. Chaudhury2, M. Chakravarty1, and B.N. Chakravarty1
1Institute of ReproductiveMedicine, ART,Kolkata, India, 2IITKharagpur, School
of Medical Science & Technology, Kharagpur, India
Study question: Altered expression of intra-follicular cytokines and angiogenic
molecules is known to inﬂuenceoocyte and embryoquality inwomenundergoing
in vitro fertilization (IVF). The objective of the present study is to explore which
molecule plays the most signiﬁcant role in affecting the IVF outcome in women
with endometriosis.
Summary answer: Interleukin-8 (IL-8) in follicular ﬂuid is identiﬁed as the key
molecule which plays the main contributory role in determining oocyte quality,
fertilization rate and embryo competence in womenwith endometriosis undergo-
ing IVF.
What is known already: A broad range of cytokines and angiogenic factors
present in the follicular ﬂuid are involved in follicular development. What still
remains unknown iswhich particularmarker, out of thesemolecules,most signiﬁ-
cantly affects IVF outcome.
Study design, size, duration: 200 women with advanced endometriosis (study
group) and 140 normal ovulating women with tubal infertility (controls), aged
26-40 years, undergoing IVF were recruited during February 2011-December
2012 for this prospective case-controlled study. Follicular ﬂuid sampleswere col-
lected at the time of oocyte retrieval from all the patients.
Participants/materials, setting, methods: Cytokines and angiogenic factors
were measured using ELISA. Multivariate statistical analyses were used to ﬁnd
the principal factor as predictive marker for IVF outcome. ROC curve was
applied to determine the optimum cut-off point for identifying the best oocytes
in women with endometriosis. The study was conducted at our institute.
Main results and the role of chance: Signiﬁcant increase in levels of cytokines
(pro-inﬂammatory: IL-1b, TNF-a, IL-2,8,12, IFN-g and anti-inﬂammatory:
IL-4,6,10) and angiogenic molecules (VEGF, adrenomedullin and angiogenin)
were observed in women with endometriosis, compared to controls. Endometri-
osis cases could be well-differentiated from controls based on PCA and
PLS-DA analysis. Further, IL-8 has been identiﬁed as the strongest contributing
factor and a potential marker for IVF outcome in endometriosis. IL-8 negatively
correlated with oocyte quality (r¼ -0.67, P, 0.001), fertilization rate (r¼ -0.54,
P, 0.001) and embryo grading (r¼ -0.58, P, 0.001). ROC curve of IL-8 indi-
cated a threshold level of 18.7 pg/ml(90.0% sensitivity, 85.7% speciﬁcity and
AUC 0.872). This marker could identify the best quality oocytes in women
with endometriosis. There is little role of chance, as most of the studies had
similar outcomes.
Limitations, reason for caution: Intra-follicular IL-8 as a marker, apart from
endometriosis, also warrants validation in other infertility cases. Multivariate
techniques are complex and should be used with adequate interpretation skills.
Wider implications of the ﬁndings: IL-8 holds promise to be a potential marker
for non-invasive assessment of oocyte quality that needs to be evaluated to select
the oocytes with high fertilization potential, and hence the embryo with high de-
velopmental and implantation potential for transfer.
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